PSTX — Poseida Therapeutics Share News
0.000.00%
Last trade - 00:00- $927.88m
- $755.94m
- $64.70m
U.S. STOCKS ON THE MOVE-BioCryst, gold miners, ChemoCentryx
Brief: Poseida Therapeutics Announces Pricing Of Public Offering Of Common Stock
Poseida Therapeutics slides on pricing $70 mln equity offering
U.S. STOCKS ON THE MOVE-Global Blood, Alibaba.com, Albemarle
Brief: Poseida Therapeutics Announces Proposed Public Offering
Brief: Poseida Therapeutics Announces Proposed Public Offering Of Common Stock
Poseida Therapeutics slips, launches equity offering after stock surges
U.S. STOCKS ON THE MOVE-Under Armour, Microchip Tech,
Nasdaq biotech index eyes best day since late 2020
U.S. STOCKS ON THE MOVE-Moderna, Ford, Meta
U.S. STOCKS ON THE MOVE-Robinhood, Poseida, Arcutis
Poseida jumps as Roche deal provides shot in the arm
Brief: Poseida Therapeutics Announces Strategic Global Collaboration With Roche Focused On Allogeneic Car-T Cell Therapies For Hematologic Malignancies
Brief: Poseida Therapeutics Announces Publication Highlighting Potential Of Cas-CLOVER™ As An Efficient And Robust Gene Editing System For Developing Allogeneic CAR-T Products
Brief: Poseida Therapeutics Presents Encouraging Preclinical Data Highlighting P-ckit-ALLO1 at the ASGCT 2022 Annual Meeting
U.S. RESEARCH ROUNDUP-Humacyte, Hyatt Hotels, Poseida Therapeutics
Poseida Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Poseida Therapeutics Reports Qtrly Loss Per Share Of $0.93
Poseida Therapeutics Inc expected to post a loss of 66 cents a share - Earnings Preview